La dernière actualité médicale WillebrandXPERT Consultez la version en ligne Chère consœur, cher confrère, Retrouvez ci-après les dernières publications scientifiques issues de revues à comité de lecture dans votre domaine d'expertise. Publications du  Samedi 11 octobre 2025 A phase 1, open-label study to assess the pharmacokinetics, safety, and tolerability of a single intravenous injection of efanesoctocog alfa in adults with type 2N or type 3 von Willebrand disease Journal of Thrombosis and Haemostasis 2026; 24(1): 79-87 Efanesoctocog alfa is a high-sustained factor (F)VIII replacement therapy for hemophilia A. The D'D3 domain of efanesoctocog alfa overcomes the von Willebrand factor–imposed half-life ceiling and... En savoir plus |  Version PDF  |  Imprimer l'abstract Prevention of hemorrhage after implantation of mechanical circulatory support with a purified von Willebrand factor concentrate: results of the early terminated randomized controlled trial Journal of Thrombosis and Haemostasis 2026; 24(2): 408-17 Bleeding complications are frequent under left ventricular assist device (LVAD) support. LVAD-associated high shear stress induces increased proteolysis of circulating von Willebrand factor (VWF), which... En savoir plus |  Version PDF  |  Imprimer l'abstract Factor VIII and von Willebrand factor activity levels during long-term prophylaxis with wilate—Analyses from the WIL-31 study Research and Practice in Thrombosis and Haemostasis 2026; 10(1): 103327 Long-term von Willebrand factor (VWF) prophylaxis is recommended for people with von Willebrand disease (VWD) who experience frequent and severe bleeds. However, repeated administration of VWF-containing... En savoir plus |  Version PDF  |  Imprimer l'abstract Pregnancy outcomes in women with Von Willebrand disease: a statewide cohort study Research and Practice in Thrombosis and Haemostasis 2026; 10(2): 103383 Multiple studies conducted between 1990s and 2010s reported increased rates of postpartum hemorrhage (PPH) among women with von Willebrand disease (VWD), even with specialized peripartum care. To generate... En savoir plus |  Version PDF  |  Imprimer l'abstract Accueil  |  Actualités  |  Archives Informer un confrère | Modifier votre profil | Se désinscrire | Sources et critères Copyright 2025 © GNM Healthcare Group Companies USA, Inc.